Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Matter Of $275 Million: Congress And White House Tussle Over FDA Funds

This article was originally published in The Gray Sheet

Executive Summary

The Bush Administration tried to get ahead of Congress' relentless criticism that it is under-funding FDA last week by adding $275 million for the agency to its fiscal year 2009 budget request. Critics on Capitol Hill were not impressed

You may also be interested in...



FDA Science Board Will Double Membership And Meetings

FDA Commissioner Andrew von Eschenbach wants to increase the impact of the agency's Science Board by doubling the number of members and meetings

FDA Science Board Will Double Membership And Meetings

FDA Commissioner Andrew von Eschenbach wants to increase the impact of the agency's Science Board by doubling the number of members and meetings

Senate Panel Clears $275 Million In Immediate Extra Funding For FDA

A supplemental appropriations/war funding measure containing $275 million for FDA cleared the Senate Appropriations Committee May 15 but faces a tougher go in both the House and the White House

UsernamePublicRestriction

Register

PS063835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel